{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:07Z","timestamp":1792801987371,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s12016-009-8193-3","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T08:29:15Z","timestamp":1263889755000},"page":"92-103","source":"Crossref","is-referenced-by-count":62,"title":["The Pathogenesis of Systemic Sclerosis Revisited"],"prefix":"10.1007","volume":"40","author":[{"given":"Matthias","family":"Geyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"8193_CR1","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.0030002","volume":"3","author":"C Lunardi","year":"2006","unstructured":"Lunardi C, Dolcino M, Peterlana D et al (2006) Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med 3:e2","journal-title":"PLoS Med"},{"key":"8193_CR2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/ard.45.7.553","volume":"45","author":"A Kahan","year":"1986","unstructured":"Kahan A, Menkes CJ, Amor B (1986) Defective Epstein\u2013Barr virus specific suppressor T cell function in progressive systemic sclerosis. Ann Rheum Dis 45:553\u2013560","journal-title":"Ann Rheum Dis"},{"key":"8193_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000232945","volume":"52","author":"K Zakrzewska","year":"2009","unstructured":"Zakrzewska K, Corcioli F, Carlsen KM et al (2009) Human parvovirus B19 (B19V) infection in systemic sclerosis patients. Intervirology 52:279\u2013282","journal-title":"Intervirology"},{"key":"8193_CR4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0007-0963.2004.05930.x","volume":"150","author":"T Ohtsuka","year":"2004","unstructured":"Ohtsuka T, Yamazaki S (2004) Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Br J Dermatol 150:1091\u20131095","journal-title":"Br J Dermatol"},{"key":"8193_CR5","first-page":"857","volume":"4","author":"RI Fox","year":"1992","unstructured":"Fox RI, Kang HI (1992) Genetic and environmental factors in systemic sclerosis. Curr Opin Rheumatol 4:857\u2013861","journal-title":"Curr Opin Rheumatol"},{"key":"8193_CR6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.1990.tb04189.x","volume":"123","author":"MH Rustin","year":"1990","unstructured":"Rustin MH, Bull HA, Ziegler V et al (1990) Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol 123:725\u2013734","journal-title":"Br J Dermatol"},{"key":"8193_CR7","first-page":"175","volume":"16","author":"N Calvani","year":"2001","unstructured":"Calvani N, Silvestris F, Dammacco F (2001) Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Ann Ital Med Int 16:175\u2013178","journal-title":"Ann Ital Med Int"},{"key":"8193_CR8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/ard.53.9.618-a","volume":"53","author":"AM Garcia-Zamalloa","year":"1994","unstructured":"Garcia-Zamalloa AM, Ojeda E, Gonzalez-Beneitez C, Goni J, Garrido A (1994) Systemic sclerosis and organic solvents: early diagnosis in industry. Ann Rheum Dis 53:618","journal-title":"Ann Rheum Dis"},{"key":"8193_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jbspin.2007.04.005","volume":"74","author":"Y Allanore","year":"2007","unstructured":"Allanore Y, Wipff J, Kahan A, Boileau C (2007) Genetic basis for systemic sclerosis. Joint Bone Spine 74:577\u2013583","journal-title":"Joint Bone Spine"},{"key":"8193_CR10","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","volume":"60","author":"P Dieude","year":"2009","unstructured":"Dieude P, Guedj M, Wipff J et al (2009) STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum 60:2472\u20132479","journal-title":"Arthritis Rheum"},{"key":"8193_CR11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00002281-200011000-00007","volume":"12","author":"FK Tan","year":"2000","unstructured":"Tan FK, Arnett FC (2000) Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon. Curr Opin Rheumatol 12:511\u2013519","journal-title":"Curr Opin Rheumatol"},{"key":"8193_CR12","first-page":"158","volume":"13","author":"G Fantonetti","year":"1838","unstructured":"Fantonetti G (1838) Case of general induration of the skin. Dublin J Med Sci 13:158\u2013159","journal-title":"Dublin J Med Sci"},{"key":"8193_CR13","first-page":"337","volume":"4","author":"RH Goetz","year":"1945","unstructured":"Goetz RH (1945) The pathology of progressive systemic sclerosis (generalised scleroderma) with special reference to changes in the viscera. Clin Proc J Cape Town Postgrad Med Ass 4:337\u2013341","journal-title":"Clin Proc J Cape Town Postgrad Med Ass"},{"key":"8193_CR14","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"8193_CR15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.bor.0000138677.88694.a4","volume":"16","author":"MB Kahaleh","year":"2004","unstructured":"Kahaleh MB (2004) Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol 16:718\u2013722","journal-title":"Curr Opin Rheumatol"},{"key":"8193_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar295","volume":"3","author":"A Scheja","year":"2001","unstructured":"Scheja A, Akesson A, Geborek P et al (2001) Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Res 3:178\u2013182","journal-title":"Arthritis Res"},{"key":"8193_CR17","first-page":"561","volume":"8","author":"M Matucci-Cerinic","year":"1990","unstructured":"Matucci-Cerinic M, Pietrini U, Marabini S (1990) Local venomotor response to intravenous infusion of substance P and glyceryl trinitrate in systemic sclerosis. Clin Exp Rheumatol 8:561\u2013565","journal-title":"Clin Exp Rheumatol"},{"key":"8193_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","volume":"32","author":"MM Cerinic","year":"2003","unstructured":"Cerinic MM, Valentini G, Sorano GG et al (2003) Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 32:285\u2013295","journal-title":"Semin Arthritis Rheum"},{"key":"8193_CR19","first-page":"S32","volume":"21","author":"NJ McHugh","year":"2003","unstructured":"McHugh NJ, Distler O, Giacomelli R, Riemekasten G (2003) Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol 21:S32\u2013S38","journal-title":"Clin Exp Rheumatol"},{"key":"8193_CR20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98:785\u2013792","journal-title":"J Clin Invest"},{"key":"8193_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb.11.4.7917311","volume":"11","author":"AD Cambrey","year":"1994","unstructured":"Cambrey AD, Harrison NK, Dawes KE et al (1994) Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol 11:439\u2013445","journal-title":"Am J Respir Cell Mol Biol"},{"key":"8193_CR22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557\u2013567","journal-title":"J Clin Invest"},{"key":"8193_CR23","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","volume":"43","author":"M Humbert","year":"2004","unstructured":"Humbert M, Morrell NW, Archer SL et al (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S\u201324S","journal-title":"J Am Coll Cardiol"},{"key":"8193_CR24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-857X(05)70295-7","volume":"22","author":"EC LeRoy","year":"1996","unstructured":"LeRoy EC (1996) Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 22:675\u2013694","journal-title":"Rheum Dis Clin North Am"},{"key":"8193_CR25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00296-009-0906-7","volume":"29","author":"JH Park","year":"2009","unstructured":"Park JH, Sung YK, Bae SC, Song SY, Seo HS, Jun JB (2009) Ulnar artery vasculopathy in systemic sclerosis. Rheumatol Int 29:1081\u20131086","journal-title":"Rheumatol Int"},{"key":"8193_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)65137-1","volume":"155","author":"CD Cool","year":"1999","unstructured":"Cool CD, Stewart JS, Werahera P et al (1999) Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 155:411\u2013419","journal-title":"Am J Pathol"},{"key":"8193_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11926-004-0057-5","volume":"6","author":"EY Rhew","year":"2004","unstructured":"Rhew EY, Barr WG (2004) Scleroderma renal crisis: new insights and developments. Curr Rheumatol Rep 6:129\u2013136","journal-title":"Curr Rheumatol Rep"},{"key":"8193_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JH, Scheid A et al (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95:109\u2013116","journal-title":"Circ Res"},{"issue":"Suppl 2","key":"8193_CR29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar2187","volume":"9","author":"AE Koch","year":"2007","unstructured":"Koch AE, Distler O (2007) Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 9(Suppl 2):S3","journal-title":"Arthritis Res Ther"},{"key":"8193_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930903002487","volume":"42","author":"U M\u00fcller-Ladner","year":"2009","unstructured":"M\u00fcller-Ladner U, Distler O, Ibba-Manneschi L, Neumann E, Gay S (2009) Mechanisms of vascular damage in systemic sclerosis. Autoimmunity 42:587\u2013595","journal-title":"Autoimmunity"},{"key":"8193_CR31","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.22035","volume":"54","author":"N Papa Del","year":"2006","unstructured":"Del Papa N, Quirici N, Soligo D et al (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54:2605\u20132615","journal-title":"Arthritis Rheum"},{"key":"8193_CR32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","volume":"364","author":"M Kuwana","year":"2004","unstructured":"Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y (2004) Defective vasculogenesis in systemic sclerosis. Lancet 364:603\u2013610","journal-title":"Lancet"},{"key":"8193_CR33","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/ard.2007.082131","volume":"67","author":"J Avouac","year":"2008","unstructured":"Avouac J, Juin F, Wipff J et al (2008) Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 67:1455\u20131460","journal-title":"Ann Rheum Dis"},{"key":"8193_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2008.091918","volume":"68","author":"JH Distler","year":"2009","unstructured":"Distler JH, Allanore Y, Avouac J et al (2009) EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 68:163\u2013168","journal-title":"Ann Rheum Dis"},{"key":"8193_CR35","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","volume":"56","author":"P Cipriani","year":"2007","unstructured":"Cipriani P, Guiducci S, Miniati I et al (2007) Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 56:1994\u20132004","journal-title":"Arthritis Rheum"},{"key":"8193_CR36","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","volume":"50","author":"S D'Alessio","year":"2004","unstructured":"D'Alessio S, Fibbi G, Cinelli M et al (2004) Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis. Arthritis Rheum 50:3275\u20133285","journal-title":"Arthritis Rheum"},{"key":"8193_CR37","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","volume":"87","author":"C Suri","year":"1996","unstructured":"Suri C, Jones PF, Patan S et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171\u20131180","journal-title":"Cell"},{"key":"8193_CR38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.yexcr.2005.09.002","volume":"312","author":"L Eklund","year":"2006","unstructured":"Eklund L, Olsen BR (2006) Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312:630\u2013641","journal-title":"Exp Cell Res"},{"key":"8193_CR39","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","volume":"43","author":"M Hebbar","year":"2000","unstructured":"Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B (2000) Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum 43:889\u2013893","journal-title":"Arthritis Rheum"},{"key":"8193_CR40","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R et al (2002) Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4:R11","journal-title":"Arthritis Res"},{"key":"8193_CR41","first-page":"125","volume":"27","author":"S Yamagishi","year":"2005","unstructured":"Yamagishi S, Imaizumi T (2005) Pericyte biology and diseases. Int J Tissue React 27:125\u2013135","journal-title":"Int J Tissue React"},{"key":"8193_CR42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.0303-6987.2004.00203.x","volume":"31","author":"P Helmbold","year":"2004","unstructured":"Helmbold P, Fiedler E, Fischer M, Marsch W (2004) Hyperplasia of dermal microvascular pericytes in scleroderma. J Cutan Pathol 31:431\u2013440","journal-title":"J Cutan Pathol"},{"key":"8193_CR43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1","volume":"42","author":"VS Rajkumar","year":"1999","unstructured":"Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM (1999) Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 42:930\u2013941","journal-title":"Arthritis Rheum"},{"key":"8193_CR44","doi-asserted-by":"crossref","first-page":"R1113","DOI":"10.1186\/ar1790","volume":"7","author":"VS Rajkumar","year":"2005","unstructured":"Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM, Abraham DJ (2005) Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther 7:R1113\u2013R1123","journal-title":"Arthritis Res Ther"},{"key":"8193_CR45","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","volume":"173","author":"SL Lin","year":"2008","unstructured":"Lin SL, Kisseleva T, Brenner DA, Duffield JS (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173:1617\u20131627","journal-title":"Am J Pathol"},{"key":"8193_CR46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","volume":"26","author":"DJ Abraham","year":"2005","unstructured":"Abraham DJ, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 26:587\u2013595","journal-title":"Trends Immunol"},{"key":"8193_CR47","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"ML Whitfield","year":"2003","unstructured":"Whitfield ML, Finlay DR, Murray JI et al (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 100:12319\u201312324","journal-title":"Proc Natl Acad Sci USA"},{"key":"8193_CR48","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","volume":"165","author":"S Sato","year":"2000","unstructured":"Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K (2000) Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 165:6635\u20136643","journal-title":"J Immunol"},{"key":"8193_CR49","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","volume":"50","author":"S Sato","year":"2004","unstructured":"Sato S, Fujimoto M, Hasegawa M, Takehara K (2004) Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50:1918\u20131927","journal-title":"Arthritis Rheum"},{"key":"8193_CR50","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2353\/ajpath.2006.060205","volume":"169","author":"M Hasegawa","year":"2006","unstructured":"Hasegawa M, Hamaguchi Y, Yanaba K et al (2006) B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 169:954\u2013966","journal-title":"Am J Pathol"},{"key":"8193_CR51","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00002281-200311000-00016","volume":"15","author":"ML Harris","year":"2003","unstructured":"Harris ML, Rosen A (2003) Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 15:778\u2013784","journal-title":"Curr Opin Rheumatol"},{"key":"8193_CR52","first-page":"450","volume":"72","author":"J Rosenbaum","year":"1988","unstructured":"Rosenbaum J, Pottinger BE, Woo P et al (1988) Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 72:450\u2013456","journal-title":"Clin Exp Immunol"},{"key":"8193_CR53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","volume":"97","author":"D Carvalho","year":"1996","unstructured":"Carvalho D, Savage CO, Black CM, Pearson JD (1996) IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 97:111\u2013119","journal-title":"J Clin Invest"},{"key":"8193_CR54","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"SS Baroni","year":"2006","unstructured":"Baroni SS, Santillo M, Bevilacqua F et al (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354:2667\u20132676","journal-title":"N Engl J Med"},{"key":"8193_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2005.03.013","volume":"39","author":"M Hasegawa","year":"2005","unstructured":"Hasegawa M, Fujimoto M, Takehara K, Sato S (2005) Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 39:1\u20137","journal-title":"J Dermatol Sci"},{"key":"8193_CR56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/ard.2002.004838","volume":"63","author":"GH Stummvoll","year":"2004","unstructured":"Stummvoll GH, Aringer M, Grisar J et al (2004) Increased transendothelial migration of scleroderma lymphocytes. Ann Rheum Dis 63:569\u2013574","journal-title":"Ann Rheum Dis"},{"key":"8193_CR57","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","volume":"168","author":"LI Sakkas","year":"2002","unstructured":"Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD (2002) Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 168:3649\u20133659","journal-title":"J Immunol"},{"key":"8193_CR58","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2741\/1654","volume":"10","author":"CM Artlett","year":"2005","unstructured":"Artlett CM (2005) Immunology of systemic sclerosis. Front Biosci 10:1707\u20131719","journal-title":"Front Biosci"},{"key":"8193_CR59","first-page":"646","volume":"23","author":"VD Steen","year":"1996","unstructured":"Steen VD, Engel EE, Charley MR, Medsger TA Jr (1996) Soluble serum interleukin 2 receptors in patients with systemic sclerosis. J Rheumatol 23:646\u2013649","journal-title":"J Rheumatol"},{"key":"8193_CR60","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.137.10.1309","volume":"137","author":"LE French","year":"2001","unstructured":"French LE, Lessin SR, Addya K et al (2001) Identification of clonal T cells in the blood of patients with systemic sclerosis: positive correlation with response to photopheresis. Arch Dermatol 137:1309\u20131313","journal-title":"Arch Dermatol"},{"key":"8193_CR61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA (2004) Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol 4:583\u2013594","journal-title":"Nat Rev Immunol"},{"key":"8193_CR62","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.166.5.3432","volume":"166","author":"A Wangoo","year":"2001","unstructured":"Wangoo A, Sparer T, Brown IN et al (2001) Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol 166:3432\u20133439","journal-title":"J Immunol"},{"key":"8193_CR63","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000098208","volume":"73","author":"G Lakos","year":"2006","unstructured":"Lakos G, Melichian D, Wu M, Varga J (2006) Increased bleomycin-induced skin fibrosis in mice lacking the Th1-specific transcription factor T-bet. Pathobiology 73:224\u2013237","journal-title":"Pathobiology"},{"key":"8193_CR64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","volume":"45","author":"FK Tan","year":"2006","unstructured":"Tan FK, Zhou X, Mayes MD et al (2006) Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 45:694\u2013702","journal-title":"Rheumatology (Oxford)"},{"key":"8193_CR65","first-page":"1751","volume":"151","author":"C Mavalia","year":"1997","unstructured":"Mavalia C, Scaletti C, Romagnani P et al (1997) Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 151:1751\u20131758","journal-title":"Am J Pathol"},{"key":"8193_CR66","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L","volume":"42","author":"SP Atamas","year":"1999","unstructured":"Atamas SP, Yurovsky VV, Wise R et al (1999) Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum 42:1168\u20131178","journal-title":"Arthritis Rheum"},{"key":"8193_CR67","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/pmic.200301007","volume":"5","author":"P Rottoli","year":"2005","unstructured":"Rottoli P, Magi B, Perari MG et al (2005) Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5:1423\u20131430","journal-title":"Proteomics"},{"key":"8193_CR68","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.11129","volume":"48","author":"C Chizzolini","year":"2003","unstructured":"Chizzolini C, Parel Y, De Luca C et al (2003) Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Arthritis Rheum 48:2593\u20132604","journal-title":"Arthritis Rheum"},{"key":"8193_CR69","first-page":"275","volume":"33","author":"T Matsushita","year":"2006","unstructured":"Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S (2006) Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 33:275\u2013284","journal-title":"J Rheumatol"},{"key":"8193_CR70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2249.2001.01603.x","volume":"125","author":"R Giacomelli","year":"2001","unstructured":"Giacomelli R, Cipriani P, Fulminis A et al (2001) Circulating gamma\/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization. Clin Exp Immunol 125:310\u2013315","journal-title":"Clin Exp Immunol"},{"key":"8193_CR71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S","volume":"41","author":"R Giacomelli","year":"1998","unstructured":"Giacomelli R, Matucci-Cerinic M, Cipriani P et al (1998) Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 41:327\u2013334","journal-title":"Arthritis Rheum"},{"key":"8193_CR72","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1073\/pnas.162488599","volume":"99","author":"HY Chang","year":"2002","unstructured":"Chang HY, Chi JT, Dudoit S et al (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 99:12877\u201312882","journal-title":"Proc Natl Acad Sci USA"},{"key":"8193_CR73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11926-007-0008-z","volume":"9","author":"DJ Abraham","year":"2007","unstructured":"Abraham DJ, Eckes B, Rajkumar V, Krieg T (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9:136\u2013143","journal-title":"Curr Rheumatol Rep"},{"key":"8193_CR74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1067-1927.2005.130102.x","volume":"13","author":"A Desmouliere","year":"2005","unstructured":"Desmouliere A, Chaponnier C, Gabbiani G (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13:7\u201312","journal-title":"Wound Repair Regen"},{"key":"8193_CR75","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG (2003) Epithelial\u2013mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776\u20131784","journal-title":"J Clin Invest"},{"key":"8193_CR76","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","volume":"9","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg M, Hanai J, Sugimoto H et al (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964\u2013968","journal-title":"Nat Med"},{"key":"8193_CR77","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.4049\/jimmunol.166.12.7556","volume":"166","author":"R Abe","year":"2001","unstructured":"Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556\u20137562","journal-title":"J Immunol"},{"key":"8193_CR78","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/art.22047","volume":"54","author":"P Cipriani","year":"2006","unstructured":"Cipriani P, Franca Milia A, Liakouli V et al (2006) Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications. Arthritis Rheum 54:3022\u20133033","journal-title":"Arthritis Rheum"},{"key":"8193_CR79","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","volume":"114","author":"RJ Phillips","year":"2004","unstructured":"Phillips RJ, Burdick MD, Hong K et al (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438\u2013446","journal-title":"J Clin Invest"},{"key":"8193_CR80","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1189\/jlb.0403170","volume":"74","author":"M Kuwana","year":"2003","unstructured":"Kuwana M, Okazaki Y, Kodama H et al (2003) Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 74:833\u2013845","journal-title":"J Leukoc Biol"},{"key":"8193_CR81","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/01.bor.0000137894.63091.1a","volume":"16","author":"J Pannu","year":"2004","unstructured":"Pannu J, Trojanowska M (2004) Recent advances in fibroblast signaling and biology in scleroderma. Curr Opin Rheumatol 16:739\u2013745","journal-title":"Curr Opin Rheumatol"},{"key":"8193_CR82","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.febslet.2006.04.033","volume":"580","author":"J Massague","year":"2006","unstructured":"Massague J, Gomis RR (2006) The logic of TGFbeta signaling. FEBS Lett 580:2811\u20132820","journal-title":"FEBS Lett"},{"key":"8193_CR83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08830189509056712","volume":"12","author":"J Varga","year":"1995","unstructured":"Varga J, Bashey RI (1995) Regulation of connective tissue synthesis in systemic sclerosis. Int Rev Immunol 12:187\u2013199","journal-title":"Int Rev Immunol"},{"key":"8193_CR84","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350\u20131358","journal-title":"N Engl J Med"},{"key":"8193_CR85","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1242\/jcs.02554","volume":"118","author":"A Moustakas","year":"2005","unstructured":"Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118:3573\u20133584","journal-title":"J Cell Sci"},{"key":"8193_CR86","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","volume":"114","author":"CE Daniels","year":"2004","unstructured":"Daniels CE, Wilkes MC, Edens M et al (2004) Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 114:1308\u20131316","journal-title":"J Clin Invest"},{"key":"8193_CR87","doi-asserted-by":"crossref","first-page":"21183","DOI":"10.1074\/jbc.M603270200","volume":"281","author":"SJ Chen","year":"2006","unstructured":"Chen SJ, Ning H, Ishida W et al (2006) The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J Biol Chem 281:21183\u201321197","journal-title":"J Biol Chem"},{"key":"8193_CR88","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/1523-1747.ep12345771","volume":"106","author":"A Igarashi","year":"1996","unstructured":"Igarashi A, Nashiro K, Kikuchi K et al (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729\u2013733","journal-title":"J Invest Dermatol"},{"key":"8193_CR89","first-page":"115","volume":"1","author":"A Leask","year":"2009","unstructured":"Leask A (2009) Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma. Front Biosci (Elite Ed) 1:115\u2013122","journal-title":"Front Biosci (Elite Ed)"},{"key":"8193_CR90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","volume":"92","author":"S Gay","year":"1989","unstructured":"Gay S, Jones RE Jr, Huang GQ, Gay RE (1989) Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 92:301\u2013303","journal-title":"J Invest Dermatol"},{"key":"8193_CR91","first-page":"1876","volume":"22","author":"A Ludwicka","year":"1995","unstructured":"Ludwicka A, Ohba T, Trojanowska M et al (1995) Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 22:1876\u20131883","journal-title":"J Rheumatol"},{"key":"8193_CR92","doi-asserted-by":"crossref","first-page":"41783","DOI":"10.1074\/jbc.M406951200","volume":"279","author":"M Jinnin","year":"2004","unstructured":"Jinnin M, Ihn H, Yamane K, Tamaki K (2004) Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. J Biol Chem 279:41783\u201341791","journal-title":"J Biol Chem"},{"key":"8193_CR93","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.173.6.4020","volume":"173","author":"M Kaviratne","year":"2004","unstructured":"Kaviratne M, Hesse M, Leusink M et al (2004) IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol 173:4020\u20134029","journal-title":"J Immunol"},{"key":"8193_CR94","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI116015","volume":"90","author":"AE Postlethwaite","year":"1992","unstructured":"Postlethwaite AE, Holness MA, Katai H, Raghow R (1992) Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90:1479\u20131485","journal-title":"J Clin Invest"},{"key":"8193_CR95","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archderm.132.7.802","volume":"132","author":"V Salmon-Ehr","year":"1996","unstructured":"Salmon-Ehr V, Serpier H, Nawrocki B et al (1996) Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol 132:802\u2013806","journal-title":"Arch Dermatol"},{"key":"8193_CR96","first-page":"328","volume":"24","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24:328\u2013332","journal-title":"J Rheumatol"},{"key":"8193_CR97","first-page":"1252","volume":"28","author":"J Tsuji-Yamada","year":"2001","unstructured":"Tsuji-Yamada J, Nakazawa M, Minami M, Sasaki T (2001) Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis. J Rheumatol 28:1252\u20131258","journal-title":"J Rheumatol"},{"key":"8193_CR98","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/art.21497","volume":"54","author":"JH Distler","year":"2006","unstructured":"Distler JH, Jungel A, Caretto D et al (2006) Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum 54:214\u2013225","journal-title":"Arthritis Rheum"},{"key":"8193_CR99","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","volume":"52","author":"M Kodera","year":"2005","unstructured":"Kodera M, Hasegawa M, Komura K, Yanaba K, Takehara K, Sato S (2005) Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis. Arthritis Rheum 52:2889\u20132896","journal-title":"Arthritis Rheum"},{"key":"8193_CR100","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI111480","volume":"74","author":"SA Jimenez","year":"1984","unstructured":"Jimenez SA, Freundlich B, Rosenbloom J (1984) Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 74:1112\u20131116","journal-title":"J Clin Invest"},{"key":"8193_CR101","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1074\/jbc.M004709200","volume":"276","author":"AK Ghosh","year":"2001","unstructured":"Ghosh AK, Yuan W, Mori Y, Chen S, Varga J (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300\/CBP transcriptional coactivators. J Biol Chem 276:11041\u201311048","journal-title":"J Biol Chem"},{"key":"8193_CR102","doi-asserted-by":"crossref","first-page":"L914","DOI":"10.1152\/ajplung.2000.278.5.L914","volume":"278","author":"T Arai","year":"2000","unstructured":"Arai T, Abe K, Matsuoka H et al (2000) Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. Am J Physiol Lung Cell Mol Physiol 278:L914\u2013L922","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"8193_CR103","doi-asserted-by":"crossref","first-page":"L841","DOI":"10.1152\/ajplung.00329.2004","volume":"288","author":"V Barbarin","year":"2005","unstructured":"Barbarin V, Xing Z, Delos M, Lison D, Huaux F (2005) Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 288:L841\u2013L848","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"8193_CR104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1523-1747.1999.00477.x","volume":"112","author":"SJ Chen","year":"1999","unstructured":"Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol 112:49\u201357","journal-title":"J Invest Dermatol"},{"key":"8193_CR105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(98)00268-6","volume":"215","author":"SJ Chen","year":"1998","unstructured":"Chen SJ, Artlett CM, Jimenez SA, Varga J (1998) Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene 215:101\u2013110","journal-title":"Gene"},{"key":"8193_CR106","doi-asserted-by":"crossref","first-page":"20399","DOI":"10.1074\/jbc.M200206200","volume":"277","author":"J Czuwara-Ladykowska","year":"2002","unstructured":"Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M (2002) Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem 277:20399\u201320408","journal-title":"J Biol Chem"},{"key":"8193_CR107","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1074\/jbc.M010133200","volume":"276","author":"J Czuwara-Ladykowska","year":"2001","unstructured":"Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M (2001) Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 276:20839\u201320848","journal-title":"J Biol Chem"},{"key":"8193_CR108","doi-asserted-by":"crossref","first-page":"47455","DOI":"10.1074\/jbc.M403477200","volume":"279","author":"AK Ghosh","year":"2004","unstructured":"Ghosh AK, Bhattacharyya S, Varga J (2004) The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells. J Biol Chem 279:47455\u201347463","journal-title":"J Biol Chem"},{"key":"8193_CR109","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.20104","volume":"50","author":"AK Ghosh","year":"2004","unstructured":"Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J (2004) Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum 50:1305\u20131318","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8193-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-009-8193-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8193-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:47Z","timestamp":1559440127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-009-8193-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["8193"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8193-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}